Latest return on equity
Telix Pharmaceuticals Return on equity
Direct answer
Telix Pharmaceuticals's return on equity is 7.36%.
The verified market snapshot reports 7.36%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Telix Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 7.36%
Explore related company data
View Telix Pharmaceuticals's market capitalizationView Telix Pharmaceuticals's p/e ratioView Telix Pharmaceuticals's price-to-book ratioView Telix Pharmaceuticals's dividend yieldView Telix Pharmaceuticals's 52-week price rangeView Telix Pharmaceuticals's revenue growthView Telix Pharmaceuticals's profit marginView Telix Pharmaceuticals's debt-to-equity ratioView all Telix Pharmaceuticals key metricsReturn to Telix Pharmaceuticals profile